We've never had a great increase in share price due to potential events such as I would classify an IND announcement or a partnership, etc.  Large price increases IMO result only from institutional investors and they won't jump in until we have a PROVEN success, whether that be B, P, or K.  Until then we may go up some (maybe $4-5 tops) but to really start the takeoff we will have to have a proven success.  I am hoping for June to really start the ball rolling as we should have had Kevetrin starring at ASCO and the Brilacidin trial completed  and possibly the Prurisol trial about to begin. 

I post what I feel because if it is proven wrong it really doesn't bother me.  I am like a chameleon, I can change my point of view as quickly as they can change color.  LOL.